ReviewAdvances in protein chemistry and structural biology2023

Insights into the aberrant CDK4/6 signaling pathway as a therapeutic target in tumorigenesis.

Abdol-Hossein Rezaeian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.